Amgen Inc
NASDAQ:AMGN

Watchlist Manager
Amgen Inc Logo
Amgen Inc
NASDAQ:AMGN
Watchlist
Price: 305.7 USD -0.4% Market Closed
Market Cap: 164.2B USD

Intrinsic Value

The intrinsic value of one AMGN stock under the Base Case scenario is 256.04 USD. Compared to the current market price of 305.7 USD, Amgen Inc is Overvalued by 16%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AMGN Intrinsic Value
256.04 USD
Overvaluation 16%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Amgen Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
AMGN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for AMGN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Amgen Inc
NASDAQ:AMGN
US
Biotechnology
Market Cap
164.1B USD
IPO
Jun 17, 1983
US
Biotechnology
Market Cap
164.1B USD
IPO
Jun 17, 1983
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

A potential wave of biosimilar competition for flagship products such as Enbrel and Otezla threatens to erode market share and pressure margins as payers increasingly turn to lower-cost alternatives.

Bull Theses

Amgen’s recent acquisitions, including its purchase of ChemoCentryx, expand its footprint in high-value rare disease and autoimmune segments, potentially offsetting sales declines from mature blockbuster drugs.

Show More Less
How do you feel about AMGN?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Amgen Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Amgen Inc

Current Assets 29B
Cash & Short-Term Investments 12B
Receivables 6.8B
Other Current Assets 10.3B
Non-Current Assets 62.8B
PP&E 6.5B
Intangibles 46.3B
Other Non-Current Assets 9.9B
Efficiency

Free Cash Flow Analysis
Amgen Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Amgen Inc

Revenue
33.4B USD
Cost of Revenue
-12.9B USD
Gross Profit
20.6B USD
Operating Expenses
-13.3B USD
Operating Income
7.3B USD
Other Expenses
-3.2B USD
Net Income
4.1B USD
Fundamental Scores

AMGN Profitability Score
Profitability Due Diligence

Amgen Inc's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive Gross Profit
Exceptional ROE
71/100
Profitability
Score

Amgen Inc's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

AMGN Solvency Score
Solvency Due Diligence

Amgen Inc's solvency score is 24/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
Low Altman Z-Score
24/100
Solvency
Score

Amgen Inc's solvency score is 24/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AMGN Price Targets Summary
Amgen Inc

Wall Street analysts forecast AMGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMGN is 326.05 USD with a low forecast of 186.85 USD and a high forecast of 408.45 USD.

Lowest
Price Target
186.85 USD
39% Downside
Average
Price Target
326.05 USD
7% Upside
Highest
Price Target
408.45 USD
34% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Apr 3, 2025
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for AMGN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AMGN Insider Trading
Buy and sell transactions by insiders

AMGN News

Other Videos
What is the Intrinsic Value of one AMGN stock?

The intrinsic value of one AMGN stock under the Base Case scenario is 256.04 USD.

Is AMGN stock undervalued or overvalued?

Compared to the current market price of 305.7 USD, Amgen Inc is Overvalued by 16%.

Back to Top